Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5698498 | Clinical Oncology | 2016 | 7 Pages |
Abstract
TBM variation between 4DCT and treatment and between SABR fractions was modest for most patients. However, 19% of patients experienced significant TBM variation that could be clinically relevant for those most severely affected. It seems prudent to carry out on-couch assessment of TBM at each SABR fraction to identify such patients who might benefit from respiratory gating or adaptive radiotherapy to maintain tumour motion within the planned limits.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
J.D. Ruben, A. Seeley, V. Panettieri, T. Ackerly,